Immix Biopharma Advances in Oncology and Inflammation with Tissue-Specific Therapies
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company making strides in oncology and inflammation therapies, with a focus on tissue-specific treatments for conditions like ulcerative colitis and Crohn’s disease.
2 minutes to read